199sek
-0,7 %
Date:2025-05-13Time:18:00:00Latest report:Q4-2023List:First NorthTicker:2CUREX
Market Cap:50 msekEnterprise Value:36 msekNet Sales:0,16 msekEarnings:-30,8 msekEmployees:0ISIN:SE0010468124

Ratios

10-year key figure history for 2cureX turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for 2cureX with index and moving average MA50 and MA200.

Stockprice:1,99
MA50:0,65
MA200:0,52
Price/MA200:278,3 %
RSI (14):81,6
Price/MA50:207,3 %

Description

2cureX focuses on cancer treatment. The company provides various tools used by doctors in treatments to measure the effect and resistance of cancer drugs on the patient's own cancer cells. The goal is to shorten the treatment period and find the right individual treatment. The largest operations are held in the European market. 2cureX is headquartered in Copenhagen.

Medical Equipment